These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 3324561)
81. Dienogest reduces proliferation, NGF expression and nerve fiber density in human adenomyosis. Takeuchi A; Koga K; Miyashita M; Makabe T; Sue F; Harada M; Hirata T; Hirota Y; Fujii T; Osuga Y Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():157-161. PubMed ID: 27865118 [TBL] [Abstract][Full Text] [Related]
82. Outcomes of treatment with cyclic administration of dienogest after ovarian endometriotic cystectomy. Yanase T; Ishida M; Nishijima S; Morikawa K; Yokoo T; Takaki Y; Tsuneki I; Tamura M; Kurabayashi T Gynecol Endocrinol; 2015; 31(8):643-6. PubMed ID: 26291801 [TBL] [Abstract][Full Text] [Related]
83. Evaluation of STS-557 as a postcoital contraceptive in the baboon. Castracane VD; Goldzieher JW Contraception; 1981 Mar; 23(3):335-9. PubMed ID: 7238048 [TBL] [Abstract][Full Text] [Related]
84. Estimating the effectiveness of emergency contraceptive pills. Trussell J; Ellertson C; von Hertzen H; Bigrigg A; Webb A; Evans M; Ferden S; Leadbetter C Contraception; 2003 Apr; 67(4):259-65. PubMed ID: 12684144 [TBL] [Abstract][Full Text] [Related]
85. Natazia--a new oral contraceptive. Med Lett Drugs Ther; 2010 Sep; 52(1346):71-2. PubMed ID: 20814403 [No Abstract] [Full Text] [Related]
86. Gestagens, danazol and antiprogestogen in emergency contraception. Webb AM Eur J Contracept Reprod Health Care; 1997 Jun; 2(2):127-9. PubMed ID: 9678102 [No Abstract] [Full Text] [Related]
87. A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis. Köhler G; Faustmann TA; Gerlinger C; Seitz C; Mueck AO Int J Gynaecol Obstet; 2010 Jan; 108(1):21-5. PubMed ID: 19819448 [TBL] [Abstract][Full Text] [Related]
88. Likelihood of conception with a single act of intercourse: providing benchmark rates for assessment of post-coital contraceptives. Wilcox AJ; Dunson DB; Weinberg CR; Trussell J; Baird DD Contraception; 2001 Apr; 63(4):211-5. PubMed ID: 11376648 [TBL] [Abstract][Full Text] [Related]
89. Postcoital contraception. Porter J; Jones W Med J Aust; 1981 Jan; 1(2):68, 85-7. PubMed ID: 7231250 [No Abstract] [Full Text] [Related]
90. Studies on the hydrogenation of the progestagen dienogest in vivo and in vitro in the female rabbit. Hobe G; Schön R; Hajek M; Undisz K; Härtl A Steroids; 1998; 63(7-8):393-400. PubMed ID: 9654645 [TBL] [Abstract][Full Text] [Related]
91. Expression of Lewis (b) blood group antigen interferes with oral dienogest therapy among women with adenomyosis. Xue J; Li L; Li F; Li N; Li T; Li C J Reprod Immunol; 2020 Feb; 137():103079. PubMed ID: 31927399 [TBL] [Abstract][Full Text] [Related]
92. Pre-and postcoital contraceptive activity of LH-RH in the rat. Beattie CW; Corbin A Biol Reprod; 1977 Apr; 16(3):333-9. PubMed ID: 321041 [No Abstract] [Full Text] [Related]
93. Long-term dienogest administration in patients with symptomatic adenomyosis. Neriishi K; Hirata T; Fukuda S; Izumi G; Nakazawa A; Yamamoto N; Harada M; Hirota Y; Koga K; Wada-Hiraike O; Fujii T; Osuga Y J Obstet Gynaecol Res; 2018 Aug; 44(8):1439-1444. PubMed ID: 29845696 [TBL] [Abstract][Full Text] [Related]